Kontakt 2025, 27(2):164-170 | DOI: 10.32725/kont.2025.019

Post COVID challenges in chronic neurological conditions: exploring perceived symptoms and the potential effect of individual physiotherapySocial Sciences in Health - Original article

Klára Novotná1, 2, *, Kristýna Dandová1, Ivana Knapová2, Dominika ©»astná1, Ingrid Menkyová1, 3, Eva Kubala Havrdová1
1 Charles University and General University Hospital in Prague, First Faculty of Medicine, Department of Neurology and Centre of Clinical Neuroscience, Prague, Czech Republic
2 General University Hospital in Prague, First Faculty of Medicine, Department of Rehabilitation Medicine, Prague, Czech Republic
3 Slovak Medical University, Faculty of Medicine, Department of Neurology, Bratislava, Slovak Republic

Background: COVID is described as having not only medical but also wider social consequences for society. Individuals may experience persistent health problems after infection. We aimed to find out whether people with chronic neurodegenerative disease (multiple sclerosis - MS) still perceive any complications after this infection. And the secondary aim was to offer them a physiotherapy.

Methods: In this single-centre study, people with MS who experienced COVID-19 between January and March 2022 were contacted and structurally asked about the occurrence of any post-COVID symptoms.

Results: In March 2023, 251 (75 men) people responded to the survey. The mean age of these people was 43.8 years (SD 8.9), and the mean disease duration 14.1 years (SD 8.3). A total of 76 people (22%) suffered from post-COVID symptoms lasting 12 weeks or longer. Most common symptoms included fatigue (55%), dyspnoe (26%), neurological deterioration (20%), and joint and muscle pain (18%).A total of 6 people participated in a pilot physiotherapy program.

Conclusion: Based on subjective reports, a considerable number of people with MS can suffer from post-COVID symptoms Our experience from a small pilot study showed that individual physiotherapy could probably relieve some of these difficulties. However, this would need to be verified in a larger sample. Knowledge of any persistent post-COVID difficulties can also help other health and social care professionals.

Keywords: COVID-19; Long-COVID; Multiple sclerosis; Physiotherapy; Post-COVID; Rehabilitation; Telerehabilitation
Grants and funding:

This study was supported by the Czech Ministry of Health project RVO-VFN64165 and the Czech Health Research Council (AZV) grant NU22-04-00193. The project has also received funding from the Czech Ministry of Education - project Cooperatio LF1, research area Neuroscience, and the project National Institute for Neurological Research (Programme EXCELES, ID project No LX22NPO5107), funded by the European Union-Next Generation EU.

Conflicts of interest:

D. ©»astná received financial support for conference travel, and/or speaker honoraria, and/or consulting fees from Novartis, Biogen, Merck, Bayer, Janssen-Cilag, and Pfizer. E. Kubala Havrdová received speaker honoraria, compensation for travel, and consultant fees from Biogen, Merck, Novartis, Sanofi, and Teva, as well as support for research activities from Biogen and Merck. None of the other authors have any conflict of interest to disclose.

Received: September 26, 2024; Revised: February 6, 2025; Accepted: March 17, 2025; Prepublished online: April 24, 2025; Published: June 23, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novotná K, Dandová K, Knapová I, ©»astná D, Menkyová I, Kubala Havrdová E. Post COVID challenges in chronic neurological conditions: exploring perceived symptoms and the potential effect of individual physiotherapy. Kontakt. 2025;27(2):164-170. doi: 10.32725/kont.2025.019.
Download citation

References

  1. . Altieri M, Capuano R, Bisecco A, d'Ambrosio A, Buonanno D, Tedeschi G, et al. (2022). The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis. Mult Scler Relat Disord 61: 103774. DOI: 10.1016/j.msard.2022.103774. Go to original source... Go to PubMed...
  2. . Appelman B, Charlton BT, Goulding RP, Kerkhoff TJ, Breedveld EA, Noort W, et al. (2024). Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun 15(1): 17. DOI: 10.1038/s41467-023-44432-3. Go to original source... Go to PubMed...
  3. . Bjornevik K, Münz C, Cohen JI, Ascherio A (2023). Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol 19(3): 160-171. DOI: 10.1038/s41582-023-00775-5. Go to original source... Go to PubMed...
  4. . Brüssow H, Timmis K (2021). COVID-19: Long covid and its societal consequences. Environ Microbiol 23(8): 4077-4091. DOI: 10.1111/1462-2920.15634. Go to original source... Go to PubMed...
  5. . Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group (2020). Persistent symptoms in patients after acute COVID-19. JAMA 324(6): 603-605. DOI: 10.1001/jama.2020.12603. Go to original source... Go to PubMed...
  6. . Carod-Artal FJ, García-Moncó JC (2021). Epidemiology, pathophysiology, and classification of the neurological symptoms of post-COVID-19 syndrome. Neurol Perspect 1: S5-S15. DOI: 10.1016/j.neurop.2021.07.005. Go to original source... Go to PubMed...
  7. . Ceban F, Leber A, Jawad MY, Yu M, Lui LMW, Subramaniapillai M, et al. (2022). Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research. Infect Dis (Lond) 54(7): 467-477. DOI: 10.1080/23744235.2022.2043560. Go to original source... Go to PubMed...
  8. . Chen Ch, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B (2022). Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis 226(9): 1593-1607. DOI: 10.1093/infdis/jiac136. Go to original source... Go to PubMed...
  9. . Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38: 101019. DOI: 10.1016/j.eclinm.2021.101019. Go to original source... Go to PubMed...
  10. . Davis HE, McCorkell L, Vogel JM, Topol JE (2023). Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21: 133-146. DOI: 10.1038/s41579-022-00846-2. Go to original source... Go to PubMed...
  11. . Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF (1994). Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 18. Suppl 1: S79-S83. DOI: 10.1093/clinids/18.supplement_1.s79. Go to original source... Go to PubMed...
  12. . Gloeckl R, Zwick RH, Fürlinger U, Schneeberger T, Leitl D, Jarosch I, et al. (2024). Practical Recommendations for Exercise Training in Patients with Long COVID with or without Post-exertional Malaise: A Best Practice Proposal. Sports Med Open 10(1): 47. DOI: 10.1186/s40798-024-00695-8. Go to original source... Go to PubMed...
  13. . Golan D, Doniger GM, Wissemann K, Zarif M, Bumstead B, Buhse M, et al. (2018). The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis. Mult Scler 24(2): 196-204. DOI: 10.1177/1352458517695470. Go to original source... Go to PubMed...
  14. . Goodwin VA, Allan L, Bethel A, Cowley A, Cross JL, Day J, et al. (2021). Rehabilitation to enable recovery from COVID-19: a rapid systematic review. Physiotherapy 111: 4-22. DOI: 10.1016/j.physio.2021.01.007. Go to original source... Go to PubMed...
  15. . Huerne K, Filion KB, Grad R, Ernst P, Gershon AS, Eisenberg MJ (2023). Epidemiological and clinical perspectives of long COVID syndrome. Am J Med Open 9: 100033. DOI: 10.1016/j.ajmo.2023.100033. Go to original source... Go to PubMed...
  16. . Kos D, Kerckhofs E, Nagels G, D'hooghe MB, Ilsbroukx S (2008). Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 22(1): 91-100. DOI: 10.1177/1545968306298934. Go to original source... Go to PubMed...
  17. . Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S (2021). More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11(1): 16144. DOI: 10.1038/s41598-021-95565-8. Go to original source... Go to PubMed...
  18. . Mikkelsen ME, Abramoff B (2022). Clinical presentation and diagnosis of adults with persistent symptoms following acute illness ("long COVID"). [online] [cit. 2024-08-06]. Available from: https://www.uptodate.com/contents/covid-19-clinical-presentation-and-diagnosis-of-adults-with-persistent-symptoms-following-acute-illness-long-covid
  19. . Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, et al. (2021). Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 325(15): 1525-1534. DOI: 10.1001/jama.2021.3331. Go to original source... Go to PubMed...
  20. . Munblit D, O'Hara ME, Akrami A, Perego E, Olliaro P, Needham DM (2022). Long COVID: aiming for a consensus. Lancet Respir Med 10(7): 632-634. DOI: 10.1016/S2213-2600(22)00135-7. Go to original source... Go to PubMed...
  21. . Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I; CoviCare Study Team (2021). Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med 174(9): 1252-1260. DOI: 10.7326/M21-0878. Go to original source... Go to PubMed...
  22. . Proal AD, VanElzakker MB (2021). Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 12: 698169. DOI: 10.3389/fmicb.2021.698169. Go to original source... Go to PubMed...
  23. . Raveenderan AV, Jaydevan R, Sashidharan S (2021). Long COVID: An overview. Diabetes Metab Syndr 15(3): 869-875. DOI: 10.1016/j.dsx.2021.04.007. Go to original source... Go to PubMed...
  24. . Rousseau BA, Bhaduri-McIntosh S (2023). Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection. Viruses 15(4): 949. DOI: 10.3390/v15040949. Go to original source... Go to PubMed...
  25. . Saladino V, Algeri D, Auriemma V (2020). The psychological and social impact of Covid-19: new perspectives of well-being. Front Psychol 11: 577684. DOI: 10.3389/fpsyg.2020.577684. Go to original source... Go to PubMed...
  26. . Scurati R, Papini N, Giussani P, Alberti G, Tringali C (2022). The challenge of long COVID-19 management: from disease molecular hallmarks to the proposal of exercise as therapy. Int J Mol Sci 23(20): 12311. DOI: 10.3390/ijms232012311. Go to original source... Go to PubMed...
  27. . Seid AA, Aychiluhm SB, Mohammed AA (2022). Effectiveness and feasibility of telerehabilitation in patients with COVID-19: a systematic review and meta-analysis. BMJ Open 12(10): e063961. DOI: 10.1136/bmjopen-2022-063961. Go to original source... Go to PubMed...
  28. . Stastna D, Menkyova I, Drahota J, Hrnciarova T, Kubala Havrdova E, Vachova M, et al. (2022). To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19vaccination and infection. Mult Scler Relat Disord 65: 104014. DOI: 10.1016/j.msard.2022.104014. Go to original source... Go to PubMed...
  29. . Stastna D, Menkyova I, Drahota J, Mazouchova A, Adamkova J, Ampapa R, et al. (2021). Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia. Mult Scler Relat Disord 54: 103104. DOI: 10.1016/j.msard.2021.103104. Go to original source... Go to PubMed...
  30. . Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. (2022). Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185(5): 881-895.e20. DOI: 10.1016/j.cell.2022.01.014. Go to original source... Go to PubMed...
  31. . Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, Walt DR (2023). Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis 76(3): e487-e490. DOI: 10.1093/cid/ciac722. Go to original source... Go to PubMed...
  32. . Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. (2020). Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 69(30): 993-998. DOI: 10.15585/mmwr.mm6930e1. Go to original source... Go to PubMed...
  33. . WHO (2021). A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. [online] [cit. 2024-11-12]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
  34. . Wong AW, Shah AS, Johnston JC, Carlsten C, Ryerson CJ (2020). Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J 56(5): 2003276. DOI: 10.1183/13993003.03276-2020. Go to original source... Go to PubMed...
  35. . Xie Y, Xu E, Bowe B, Al-Aly Z (2022). Long-term cardiovascular outcomes of COVID-19. Nat Med 28(3): 583-590. DOI: 10.1038/s41591-022-01689-3. Go to original source... Go to PubMed...
  36. . Ziauddeen N, Gurdasani D, O'Hara ME, Hastie C, Roderick P, Yao G, Alwan NA (2022). Characteristics and impact of Long Covid: Findings from an online survey. PloS One 17(3): e0264331. DOI: 10.1371/journal.pone.0264331. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.